Project Grant HT94252410395
- This $1,994,937 federal Project Grant award, funded by the U.S. Department of Defense through the Military Medical Research and Development program (CFDA 12.420), is supporting research to confirm the effectiveness of acupuncture in treating the symptoms of Gulf War Illness. The grant recipient, Beth Israel Deaconess Medical Center, Inc. (Bidmc), a prominent academic medical center in Boston, will conduct this research project over a 4-year period from August 2024 to July 2028. Bidmc has...
- The Defense Health Agency awarded a $553,725 Project Grant to the University of California, Berkeley under the Military Medical Research and Development program (CFDA 12.420) to confirm the effectiveness of acupuncture in treating the symptoms of Gulf War Illness. The grant, which runs from August 1, 2024 to July 31, 2028, will enable UC Berkeley to conduct research to determine whether acupuncture provides a viable treatment option for the medical issues affecting veterans of the Gulf War. As a...
- This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
- This $300,378 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research at the University of Arizona to identify a male-specific mechanism of nociceptor sensitization that promotes migraine in active-duty service members and veterans. The research aims to develop new treatments, diagnostic tools, and clinical practice guidelines to improve the health and care of military personnel and their families. As an...
- This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...
- This federal Project Grant award of $602,900.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund a study comparing cognitive behavioral therapy and acupuncture for managing chronic pain, titled "COMPARING COGNITIVE BEHAVIORAL THERAPY AND ACUPUNCTURE FOR MANAGING CHRONIC PAIN (COMBAT-PAIN)". The award was made to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a...
- The Defense Health Agency has awarded a $1,626,500.00 Project Grant to the University of California, Los Angeles (UCLA) under the Military Medical Research and Development program (CFDA 12.420). This grant, awarded on September 15, 2025, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The grant funds a range of research initiatives across medical domains such as cancer, neuroscience, infectious diseases, and...
- This federal Project Grant award, totaling $3,602,532.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports the development of a sustained-release drug delivery device to manage biofilm implant-related infections in the spine and lateral femur. The primary awardee is the University of Utah, which has a strong track record of executing complex medical research projects for federal agencies. The...
- The federal Project Grant award of $1,214,375.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is funding a research project led by Yale University. The project is investigating the use of decoy-resistant IL-18 and immune checkpoint inhibitors in preclinical murine and ex vivo patient-derived models of renal cell carcinoma. The award began on September 15, 2024 and is set to conclude on September 14, 2028. The Military Medical Research...
- This federal Project Grant award of $369,872 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Utah. The funding supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research, titled "Temporal Coding of the Human Auditory Nerve," will be conducted from September 1, 2025 through August 31, 2027 at the University of...
This federal Project Grant award of $1,539,865.00, issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), is supporting research at the University of Utah to confirm the effectiveness of acupuncture in treating the symptoms of Gulf War Illness. The project, set to run from August 1, 2024 to July 31, 2028, will leverage the university's expertise in biomedical research and healthcare services to advance knowledge in this critical area. The Military Medical Research and Development program supports a broad range of investigative projects across medical disciplines to improve health outcomes for military service members, veterans, and the general public. This award demonstrates the university's strong capabilities in securing federal grant funding for cutting-edge research initiatives that address important societal challenges.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.5m | 7/8/24 |